201 related articles for article (PubMed ID: 22537736)
21. The Association of Gender, Age, Efavirenz Use, and Hypovitaminosis D Among HIV-Infected Adults Living in the Tropics.
Avihingsanon A; Kerr SJ; Ramautarsing RA; Praditpornsilpa K; Sophonphan J; Ubolyam S; Avihingsanon Y; Khovidhunkit W; Hiransuthikul N; Ruxrungtham K
AIDS Res Hum Retroviruses; 2016 Apr; 32(4):317-24. PubMed ID: 26413903
[TBL] [Abstract][Full Text] [Related]
22. Efficacy of vitamin D
Sudfeld CR; Mugusi F; Aboud S; Nagu TJ; Wang M; Fawzi WW
Trials; 2017 Feb; 18(1):66. PubMed ID: 28183335
[TBL] [Abstract][Full Text] [Related]
23. Antiretroviral-naïve HIV-infected patients had lower bone formation markers than HIV-uninfected adults.
Wattanachanya L; Jantrapakde J; Avihingsanon A; Ramautarsing R; Kerr S; Trachunthong D; Pussadee K; Teeratakulpisarn N; Jadwattanakul T; Chaiwatanarat T; Buranasupkajorn P; Phanuphak N; Sunthornyothin S; Phanuphak P;
AIDS Care; 2020 Aug; 32(8):984-993. PubMed ID: 31137948
[TBL] [Abstract][Full Text] [Related]
24. Pharmacodynamics of efavirenz 400 mg in treatment-naïve Chinese HIV-infected patients in a prospective cohort study.
Xu L; Peng W; Song X; Li Y; Han Y; Zhu T; Fu Q; Du X; Cao W; Li T
BMC Infect Dis; 2021 Jan; 21(1):112. PubMed ID: 33485301
[TBL] [Abstract][Full Text] [Related]
25. Resistance patterns selected by nevirapine vs. efavirenz in HIV-infected patients failing first-line antiretroviral treatment: a bayesian analysis.
Ngo-Giang-Huong N; Jourdain G; Amzal B; Sang-a-gad P; Lertkoonalak R; Eiamsirikit N; Tansuphasawasdikul S; Buranawanitchakorn Y; Yutthakasemsunt N; Mekviwattanawong S; McIntosh K; Lallemant M;
PLoS One; 2011; 6(11):e27427. PubMed ID: 22132100
[TBL] [Abstract][Full Text] [Related]
26. Higher serum 25-hydroxyvitamin D concentrations are associated with active pulmonary tuberculosis in hospitalised HIV infected patients in a low income tropical setting: a cross sectional study.
Musarurwa C; Zijenah LS; Mhandire DZ; Bandason T; Mhandire K; Chipiti MM; Munjoma MW; Mujaji WB
BMC Pulm Med; 2018 May; 18(1):67. PubMed ID: 29739378
[TBL] [Abstract][Full Text] [Related]
27. CYP2B6 (c.516G-->T) and CYP2A6 (*9B and/or *17) polymorphisms are independent predictors of efavirenz plasma concentrations in HIV-infected patients.
Kwara A; Lartey M; Sagoe KW; Rzek NL; Court MH
Br J Clin Pharmacol; 2009 Apr; 67(4):427-36. PubMed ID: 19371316
[TBL] [Abstract][Full Text] [Related]
28. Combined calcium and vitamin D supplementation is not superior to calcium supplementation alone in improving disturbed bone metabolism in patients with congestive heart failure.
Schleithoff SS; Zittermann A; Tenderich G; Berthold HK; Stehle P; Koerfer R
Eur J Clin Nutr; 2008 Dec; 62(12):1388-94. PubMed ID: 17684525
[TBL] [Abstract][Full Text] [Related]
29. Intensification of a triple-nucleoside regimen with tenofovir or efavirenz in HIV-1-infected patients with virological suppression.
Gulick RM; Lalama CM; Ribaudo HJ; Shikuma CM; Schackman BR; Schouten J; Squires KE; Koletar SL; Pilcher CD; Reichman RC; Klingman KL; Kuritzkes DR
AIDS; 2007 Apr; 21(7):813-23. PubMed ID: 17415036
[TBL] [Abstract][Full Text] [Related]
30. CYP2B6 Genetic Polymorphisms, Depression, and Viral Suppression in Adults Living with HIV Initiating Efavirenz-Containing Antiretroviral Therapy Regimens in Uganda: Pooled Analysis of Two Prospective Studies.
Chang JL; Lee SA; Tsai AC; Musinguzi N; Muzoora C; Bwana B; Boum Y; Haberer JE; Hunt PW; Martin J; Bangsberg DR; Kroetz DL; Siedner MJ
AIDS Res Hum Retroviruses; 2018 Nov; 34(11):982-992. PubMed ID: 29973058
[TBL] [Abstract][Full Text] [Related]
31. Class-sparing regimens for initial treatment of HIV-1 infection.
Riddler SA; Haubrich R; DiRienzo AG; Peeples L; Powderly WG; Klingman KL; Garren KW; George T; Rooney JF; Brizz B; Lalloo UG; Murphy RL; Swindells S; Havlir D; Mellors JW;
N Engl J Med; 2008 May; 358(20):2095-106. PubMed ID: 18480202
[TBL] [Abstract][Full Text] [Related]
32. Increased risk of dizziness in human immunodeficiency virus-infected patients taking zidovudine and efavirenz combination: a Brazilian cohort study.
Valeriano JJLS; Carvalho-Silva WHV; Coelho AVC; Moura RR; Arraes LC; Brandão LAC; Crovella S; Guimarães RL
J Pharm Pharmacol; 2020 May; 72(5):719-727. PubMed ID: 32043598
[TBL] [Abstract][Full Text] [Related]
33. Vitamin D supplementation, bone turnover, and inflammation in HIV-infected patients.
Benguella L; Arbault A; Fillion A; Blot M; Piroth C; Denimal D; Duvillard L; Ornetti P; Chavanet P; Maillefert JF; Piroth L
Med Mal Infect; 2018 Oct; 48(7):449-456. PubMed ID: 29661598
[TBL] [Abstract][Full Text] [Related]
34. The Rise and Fall of Efavirenz.
Cluck D; Lewis P; Durham SH; Hester EK
J Int Assoc Provid AIDS Care; 2016 May; 15(3):181-3. PubMed ID: 26858315
[No Abstract] [Full Text] [Related]
35. Prospective cohort study of vitamin D deficiency in pregnancy: Prevalence and limited effectiveness of 1000 IU vitamin D supplementation.
Abdelmageed RM; Hussein SMM; Anamangadan SM; Abdullah RWM; Rauf L; AlFehaidi AS; Hamed E
Womens Health (Lond); 2024; 20():17455057231222404. PubMed ID: 38282449
[TBL] [Abstract][Full Text] [Related]
36. Impaired sperm motility in HIV-infected men: an unexpected adverse effect of efavirenz?
Frapsauce C; Grabar S; Leruez-Ville M; Launay O; Sogni P; Gayet V; Viard JP; De Almeida M; Jouannet P; Dulioust E
Hum Reprod; 2015 Aug; 30(8):1797-806. PubMed ID: 26085581
[TBL] [Abstract][Full Text] [Related]
37. Nutritional supplementation of hop rho iso-alpha acids, berberine, vitamin D₃, and vitamin K₁ produces a favorable bone biomarker profile supporting healthy bone metabolism in postmenopausal women with metabolic syndrome.
Lamb JJ; Holick MF; Lerman RH; Konda VR; Minich DM; Desai A; Chen TC; Austin M; Kornberg J; Chang JL; Hsi A; Bland JS; Tripp ML
Nutr Res; 2011 May; 31(5):347-55. PubMed ID: 21636012
[TBL] [Abstract][Full Text] [Related]
38. Vitamin D supplementation and bone markers in ambulatory children on long-term valproic acid therapy. A prospective interventional study.
Papassava M; Nakou I; Siomou E; Cholevas V; Challa A; Tzoufi M
Epilepsy Behav; 2019 Aug; 97():192-196. PubMed ID: 31252278
[TBL] [Abstract][Full Text] [Related]
39. Efavirenz biotransformation as an up-stream event of mood changes in HIV-infected patients.
Grilo NM; Correia MJ; Sequeira C; Harjivan SG; Caixas U; Diogo LN; Marques MM; Monteiro EC; Antunes AM; Pereira SA
Toxicol Lett; 2016 Oct; 260():28-35. PubMed ID: 27543169
[TBL] [Abstract][Full Text] [Related]
40. Neuropsychiatric symptoms associated with efavirenz: prevalence, correlates, and management. A neurobehavioral review.
Muñoz-Moreno JA; Fumaz CR; Ferrer MJ; González-García M; Moltó J; Negredo E; Clotet B
AIDS Rev; 2009; 11(2):103-9. PubMed ID: 19529750
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
